您的位置: 首页 > 农业专利 > 详情页

Quinoxaline compound
专利权人:
Astellas Pharma Inc.
发明人:
Kaizawa, Hiroyuki,Sugita, Mari,Yamamoto, Hirofumi,Kamijo, Kazunori,Tsuchiya, Kazuyuki,Seo, Ryushi,Yamamoto, Satoshi
申请号:
AU2011299936
公开号:
AU2011299936A1
申请日:
2011.09.06
申请国别(地区):
AU
年份:
2013
代理人:
摘要:
[Problem] To provide a compound that has the effect of inhibiting PDE9 and is useful as an active ingredient in a therapeutic and/or prophylactic agent for urine collection disorders, urination disorders, diseases of the bladder and urinary system, and the like. [Solution] Investigating compounds that have the effect of inhibiting PDE9 and are useful as active ingredients in a therapeutic and/or prophylactic agent for urine collection disorders, urination disorders, diseases of the bladder and urinary system, and the like, the inventors of the present invention verified that an imidazoquinoxaline compound or a triazolo-quinoxaline compound has the effect of inhibiting PDE9, thereby completing the present invention. This imidazoquinoxaline compound or triazolo-quinoxaline compound has the effect of inhibiting PDE9 and can be used a therapeutic and/or prophylactic agent for urine collection disorders, urination disorders, diseases of the bladder and urinary system, and the like.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/
相关发明人
相关专利

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充